AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma

NCT00562380 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma
Prostate Cancer
Sarcoma
Small Intestine Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: ganitumab
OTHER: laboratory biomarker analysis
OTHER: pharmacological study
PROCEDURE: biopsy

Sponsor

Amgen

Collaborators

[object Object]